146 related articles for article (PubMed ID: 16865752)
1. Azanonaboranes containing imidazole derivatives for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
El-Zaria ME; Genady AR; Gabel D
Chemistry; 2006 Oct; 12(31):8084-9. PubMed ID: 16865752
[TBL] [Abstract][Full Text] [Related]
2. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
Genady AR
Eur J Med Chem; 2009 Jan; 44(1):409-16. PubMed ID: 18407378
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of a novel functionalized azanonaborane cluster for boron neutron capture therapy.
Genady AR
Org Biomol Chem; 2005 Jun; 3(11):2102-8. PubMed ID: 15917896
[TBL] [Abstract][Full Text] [Related]
4. New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells.
Lindström P; Olsson P; Malmqvist J; Pettersson J; Lemmen P; Werner B; Sjöberg S; Olin A; Carlsson J
Anticancer Drugs; 1994 Feb; 5(1):43-52. PubMed ID: 8186429
[TBL] [Abstract][Full Text] [Related]
5. Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model.
Petersen MS; Petersen CC; Agger R; Sutmuller M; Jensen MR; Sørensen PG; Mortensen MW; Hansen T; Bjørnholm T; Gundersen HJ; Huiskamp R; Hokland M
Anticancer Res; 2008; 28(2A):571-6. PubMed ID: 18506994
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of (aminoalkylamine)-N-aminoalkyl)azanonaborane(11) derivatives for boron neutron capture therapy.
El-Zaria ME; Dörfler U; Gabel D
J Med Chem; 2002 Dec; 45(26):5817-9. PubMed ID: 12477367
[TBL] [Abstract][Full Text] [Related]
7. Azanonaboranes [(RNH(2))B(8)H(11)NHR] as possible new compounds for use in boron neutron capture therapy.
Bauer C; Gabel D; Dörfler U
Eur J Med Chem; 2002 Aug; 37(8):649-57. PubMed ID: 12161062
[TBL] [Abstract][Full Text] [Related]
8. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
[TBL] [Abstract][Full Text] [Related]
9. Boron-containing thiouracil derivatives for neutron-capture therapy of melanoma.
Tjarks W; Gabel D
J Med Chem; 1991 Jan; 34(1):315-9. PubMed ID: 1992132
[TBL] [Abstract][Full Text] [Related]
10. closo-borane conjugated regulatory peptides retain high biological affinity: synthesis of closo-borane conjugated Tyr(3)-octreotate derivatives for BNCT.
Betzel T; Hess T; Waser B; Reubi JC; Roesch F
Bioconjug Chem; 2008 Sep; 19(9):1796-802. PubMed ID: 18712900
[TBL] [Abstract][Full Text] [Related]
11. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
12. A bystander effect observed in boron neutron capture therapy: a study of the induction of mutations in the HPRT locus.
Kinashi Y; Masunaga S; Nagata K; Suzuki M; Takahashi S; Ono K
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):508-14. PubMed ID: 17418970
[TBL] [Abstract][Full Text] [Related]
13. Biological evaluation of dodecaborate-containing L-amino acids for boron neutron capture therapy.
Hattori Y; Kusaka S; Mukumoto M; Uehara K; Asano T; Suzuki M; Masunaga S; Ono K; Tanimori S; Kirihata M
J Med Chem; 2012 Aug; 55(15):6980-4. PubMed ID: 22788992
[TBL] [Abstract][Full Text] [Related]
14. Porphyrin complexes containing coordinated BOB groups: synthesis, chemical reactivity and the structure of [BOB(tpClpp)]2+.
Belcher WJ; Hodgson MC; Sumida K; Torvisco A; Ruhlandt-Senge K; Ware DC; Boyd PD; Brothers PJ
Dalton Trans; 2008 Mar; (12):1602-14. PubMed ID: 18335144
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the interactions of polyhedral borane anions with serum albumins.
McVey WJ; Matthews B; Motley DM; Linse KD; Blass DP; Booth RE; Feakes DA
J Inorg Biochem; 2008 Apr; 102(4):943-51. PubMed ID: 18255155
[TBL] [Abstract][Full Text] [Related]
16. Thermal neutron dosimeter by synthetic single crystal diamond devices.
Almaviva S; Marinelli M; Milani E; Prestopino G; Tucciarone A; Verona C; Verona-Rinati G; Angelone M; Pillon M
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S183-5. PubMed ID: 19375336
[TBL] [Abstract][Full Text] [Related]
17. Boron(8) substituted nitrilium and ammonium derivatives, versatile cobalt bis(1,2-dicarbollide) building blocks for synthetic purposes.
Sícha V; Plesek J; Kvícalová M; Císarová I; Grüner B
Dalton Trans; 2009 Feb; (5):851-60. PubMed ID: 19156279
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, liposomal preparation, and in vitro toxicity of two novel dodecaborate cluster lipids for boron neutron capture therapy.
Justus E; Awad D; Hohnholt M; Schaffran T; Edwards K; Karlsson G; Damian L; Gabel D
Bioconjug Chem; 2007; 18(4):1287-93. PubMed ID: 17569498
[TBL] [Abstract][Full Text] [Related]
19. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
20. Implications for clinical treatment from the micrometer site dosimetric calculations in boron neutron capture therapy.
Nichols TL; Kabalka GW; Miller LF; McCormack MT; Johnson A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S161-3. PubMed ID: 19375932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
